We are monitoring the impact of COVID-19 on ADHD Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 264
Share on
Share on

Global Attention Deficit Hyperactivity Disorder Therapeutics Market Size, Share, Trends, Growth Analysis Report – Segmented Based on Treatment by Medication, Psychotherapy, Education or Training and Region - Industry Forecast | 2019 to 2024

Pulished: August, 2019
ID: 264
Pages: 175

ADHD Therapeutics Market Size & Growth (2019 to 2024)

The global attention deficit hyperactivity disorder therapeutics market size to reach USD 17.5 billion by 2024 from USD 27.1 billion in 2019. The market is growing at a CAGR of 9.09% during the forecast period. 

Attention deficit hyperactivity is a neurodevelopmental disorder which damages and envelops symptoms of impulsivity and hyperactivity. Treating and controlling the disease with the help of technology defines, neurobehavioral because the way the brain affects learning, behaviour and emotion. 

MARKET DRIVERS

The growing incidence of Attention deficit hyperactivity disorder across the world is fundamentally driving the market growth.

The causes of ADHD are still indistinct, although genetic presence is observed in many cases. As per the data given by the centres for Disease Control and Prevention (CDC) in 2016, around 6.1 million individuals, including 388,000 children aged 2–5 years, 4 million 6–11 years, and 3 million 12–17 years, were diagnosed with ADHD in the U.S. besides, boys are more likely to be diagnosed than girls. 

Frequency of ADHD is rising at a higher rate, which is to drive the growth of global attention-deficit hyperactivity disorder therapeutics market, as there is no treatment for this disorder. The ADHD therapeutics market is mostly driven by the rough impact of unstable lifestyles and additives in children's diet, increasing incidence of ADHD within the 4 to 17 year age group. Moreover, increasing awareness concerning syndrome among physicians and patients, and opinion-based as a result of the lack of regular diagnostic tests is anticipated to fuel revenue growth of the worldwide ADHD market in the coming future.

Additionally, increasing advancements in the medical field, a growing number of researches in neurosciences, raising awareness about mental illness among people are fuelling the market growth to a considerable extent. Furthermore, expanding the focus of biotechnology & pharmaceutical companies into developing the innovative therapeutics for ADHD are driving the growth of the global attention deficit hyperactivity disorder therapeutics market.

MARKET CHALLENGES

The high cost of the ADHD medications, improper reimbursement policies, and side effects related to ADHD medications (such as insomnia, anorexia, dizziness, headaches, and mood changes) are restraining the growth of global attention deficit hyperactivity disorder therapeutics market.

All the side effects associated with ADHD drugs are affecting the lives of the patients, which will be the reason for hampering revenue growth of the attention-deficit hyperactivity disorder therapeutics market in the given forecast period. Problems like allergic reactions to medicine, medical conditions like coronary artery disease, kidney disease, seizures are associated with Attention deficit hyperactivity disorder medicines.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Production Technologies and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global attention deficit hyperactivity disorder therapeutics market has been segmented and sub-segmented based on the Type, Production Technologies and Region. 

ADHD Therapeutics Market - Treatment by Medication:

  • Stimulants
    • Amphetamines 
    • Methylphenidate             
    • Dextroamphetamine      
    • Dexmethylphenidate     
  • Non-Stimulants
    • Atomoxetine      
    • Bupropion           
    • Guanfacine       

Based on the medication types, stimulants are expected to emerge as the drugs of choice, both among physicians and patients worldwide. Amphetamine is also to gain popularity over the forecast period.  

ADHD Therapeutics Market - Treatment by Psychotherapy:

  • Behaviour Therapy
  • Cognitive Behavioral Therapy
  • Interpersonal Psychotherapy
  • Family Therapy

ADHD Therapeutics Market - Treatment by Education or Training:

  • Parent Management Training
  • Social Skills Training
  • School-Based Interventions

Regional Analysis

North America commanded the highest share of 36.0% of the global attention deficit hyperactivity disorder therapeutics market in 2019. In contrast, Asia-Pacific is estimated to grow at the highest CAGR of 12.30% during the forecast period 2019 to 2024.

North America leads the ADHD therapeutics market with the largest market share. The growing rate of patients in Attention deficit hyperactivity disorder and high expenditure on healthcare is responsible for the regional market growth. It is the reason behind the large revenue pocket of the local market in the U.S. The region would hold its leading position in the global Attention deficit hyperactivity disorder therapeutics market in the forecast period. 

European Attention deficit hyperactivity disorder market holds the second-most position along with the emerging technology and digital medicines. The affluent medical device market and growing healthcare expenditure are responsible for the growth of the market. 

The Asia Pacific region is also increasing in the Attention deficit hyperactivity disorder therapeutics market. The factors which are responsible for the growth of the market are the unmet needs and sizeable patient population also the availability of lower-cost drugs for the ADHD treatment. Moreover, improving the economy in the region is acting as a key to the success of pushing up the regional market and boosting the healthcare sector. Private organizations and the increased funding from the population are responsible for the growth of the regional market. The explosion of healthcare insurance in many countries like Malaysia, Thailand, and Vietnam are expected to drive the ADHD market in the Asia Pacific region. Also, the availability of the new treatments along with the technology, affect the growing demand and to propel the growth of the regional ADHD therapeutics market.

List of key market players dominating the global attention deficit hyperactivity disorder therapeutics market profiled in the report are Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.) and Curemark, LLC. (U.S.).

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Introduction                                               

                5.2 Treatment By Medication                                    

                                5.2.1 Introduction                           

                                5.2.2 Stimulants                               

                                                5.2.2.1 Introduction       

                                                5.2.2.2 Amphetamines 

                                                5.2.2.3 Methylphenidate             

                                                5.2.2.4 Dextroamphetamine      

                                                5.2.2.5 Dexmethylphenidate     

                                5.2.3 Non-Stimulants                     

                                                5.2.3.1 Introduction       

                                                5.2.3.2 Atomoxetine      

                                                5.2.3.3 Bupropion           

                                                5.2.3.4 Guanfacine         

                5.3 Treatment By Psychotherapy                                             

                                5.3.1 Introduction                           

                                5.3.2 Behavior Therapy                 

                                5.3.3 Cognitive Behavioral Therapy                         

                                5.3.4 Interpersonal Psychotherapy                         

                                5.3.5 Family Therapy                      

                5.4 Treatment By Education or Training                                 

                                5.3.1 Introduction                           

                                5.3.2 Parent Management Training                         

                                5.3.3 Social Skills Training                             

                                5.3.4 School-Based Interventions                            

  1. Geographical Analysis

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                            

                                6.2.6 France                       

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                         

                                6.3.5 Australia                   

                                6.3.6 Soth Korea                              

                6.4 Latin America                                             

                                6.4.1 Introduction                           

                                6.4.2 Brazil                          

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                6.5 Middle East & Africa                                               

                                6.5.1 Introduction                           

                                6.5.2 Middle East                             

                                6.5.3 South Africa                            

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 Shire plc (Ireland)                                    

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Neos Therapeutics, Inc. (U.S.)                                            

                8.3 Eli Lilly and Company (U.S.)                                  

                8.4 Pfizer Inc. (U.S.)                                       

                8.5 Alcobra Ltd. (Israel)                                 

                8.6 Supernus Pharmaceuticals, Inc. (U.S.)                                            

                8.7 Noven Pharmaceuticals, Inc. (U.S.)                                  

                8.8 Novartis AG (Switzerland)                                    

                8.9 Johnson & Johnson (U.S.)                                    

                8.10 Curemark, LLC., (U.S.)                                         

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

     Appendix                                                          

a) List of Tables

b) List of Figures

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  2. Global Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  3. Global Stimulants Market By Region, From 2019-2024 (USD Billion)
  4. Global Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  5. Global Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  6. Global Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  7. Global Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  8. Global Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  9. Global Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  10. Global Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  11. Global Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  12. Global Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  13. Global School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  14. Global Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  15. Global Amphetamines Market By Region, From 2019-2024 (USD Billion)
  16. Global Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  17. Global Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  18. Global Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  19. Global Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  20. Global Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  21. Global Bupropion Market By Region, From 2019-2024 (USD Billion)
  22. Global Guanfacine Market By Region, From 2019-2024 (USD Billion)
  23. North America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  24. North America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  25. North America Stimulants Market By Region, From 2019-2024 (USD Billion)
  26. North America Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  27. North America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  28. North America Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  29. North America Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  30. North America Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  31. North America Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  32. North America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  33. North America Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  34. North America Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  35. North America School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  36. United States Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  37. United States Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  38. United States Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  39. Canada Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  40. Canada Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  41. Canada Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  42. North America Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  43. North America Amphetamines Market By Region, From 2019-2024 (USD Billion)
  44. North America Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  45. North America Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  46. North America Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  47. United States Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  48. Canada Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  49. North America Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  50. North America Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  51. North America Bupropion Market By Region, From 2019-2024 (USD Billion)
  52. North America Guanfacine Market By Region, From 2019-2024 (USD Billion)
  53. United States Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  54. Canada Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  55. Europe Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  56. Europe Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  57. Europe Stimulants Market By Region, From 2019-2024 (USD Billion)
  58. Europe Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  59. Europe Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  60. Europe Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  61. Europe Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  62. Europe Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  63. Europe Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  64. Europe Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  65. Europe Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  66. Europe Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  67. Europe School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  68. U.K Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  69. U.K Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  70. U.K Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  71. Spain Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  72. Spain Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  73. Spain Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  74. Germany Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  75. Germany Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  76. Germany Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  77. Italy Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  78. Italy Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  79. Italy Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  80. France Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  81. France Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  82. France Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  83. Europe Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  84. Europe Amphetamines Market By Region, From 2019-2024 (USD Billion)
  85. Europe Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  86. Europe Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  87. Europe Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  88. U.K Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  89. Spain Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  90. Germany Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  91. Italy Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  92. France Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  93. Europe Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  94. Europe Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  95. Europe Bupropion Market By Region, From 2019-2024 (USD Billion)
  96. Europe Guanfacine Market By Region, From 2019-2024 (USD Billion)
  97. U.K Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  98. Spain Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  99. Germany Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  100. Italy Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  101. France Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  102. Asia-Pacific Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  103. Asia-Pacific Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  104. Asia-Pacific Stimulants Market By Region, From 2019-2024 (USD Billion)
  105. Asia-Pacific Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  106. Asia-Pacific Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  107. Asia-Pacific Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  108. Asia-Pacific Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  109. Asia-Pacific Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  110. Asia-Pacific Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  111. Asia-Pacific Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  112. Asia-Pacific Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  113. Asia-Pacific Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  114. Asia-Pacific School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  115. China Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  116. China Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  117. China Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  118. India Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  119. India Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  120. India Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  121. Japan Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  122. Japan Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  123. Japan Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  124. South Korea Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  125. South Korea Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  126. South Korea Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  127. Australia Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  128. Australia Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  129. Australia Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  130. Asia-Pacific Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  131. Asia-Pacific Amphetamines Market By Region, From 2019-2024 (USD Billion)
  132. Asia-Pacific Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  133. Asia-Pacific Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  134. Asia-Pacific Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  135. China Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  136. India Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  137. Japan Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  138. South Korea Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  139. Australia Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  140. Asia-Pacific Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  141. Asia-Pacific Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  142. Asia-Pacific Bupropion Market By Region, From 2019-2024 (USD Billion)
  143. Asia-Pacific Guanfacine Market By Region, From 2019-2024 (USD Billion)
  144. China Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  145. India Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  146. Japan Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  147. South Korea Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  148. Australia Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  149. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  150. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  151. Latin America Stimulants Market By Region, From 2019-2024 (USD Billion)
  152. Latin America Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  153. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  154. Latin America Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  155. Latin America Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  156. Latin America Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  157. Latin America Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  158. Latin America Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  159. Latin America Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  160. Latin America Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  161. Latin America School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  162. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  163. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  164. Brazil Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  165. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  166. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  167. Argentina Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  168. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  169. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  170. Mexico Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  171. Latin America Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  172. Latin America Amphetamines Market By Region, From 2019-2024 (USD Billion)
  173. Latin America Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  174. Latin America Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  175. Latin America Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  176. Brazil Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  177. Argentina Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  178. Mexico Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  179. Latin America Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  180. Latin America Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  181. Latin America Bupropion Market By Region, From 2019-2024 (USD Billion)
  182. Latin America Guanfacine Market By Region, From 2019-2024 (USD Billion)
  183. Brazil Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  184. Argentina Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  185. Mexico Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  186. Middle East & Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Region, From 2019-2024 (USD Billion)
  187. Middle East & Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  188. Middle East & Africa Stimulants Market By Region, From 2019-2024 (USD Billion)
  189. Middle East & Africa Non-Stimulants Market By Region, From 2019-2024 (USD Billion)
  190. Middle East & Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  191. Middle East & Africa Behavior Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  192. Middle East & Africa Cognitive Behavioral Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  193. Middle East & Africa Interpersonal Psychotherapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  194. Middle East & Africa Family Therapy ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  195. Middle East & Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  196. Middle East & Africa Parent Management Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  197. Middle East & Africa Social Skills Training ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  198. Middle East & Africa School-based Interventions ADHD Therapeutics Market By Region, From 2019-2024 (USD Billion)
  199. Middle East Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  200. Middle East Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  201. Middle East Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  202. Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Medication, From 2019-2024 (USD Billion)
  203. Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Psychotherapy, From 2019-2024 (USD Billion)
  204. Africa Attention-Deficit Hyperactivity Disorder Therapeutics Market By Education or Training, From 2019-2024 (USD Billion)
  205. Middle East & Africa Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  206. Middle East & Africa Amphetamines Market By Region, From 2019-2024 (USD Billion)
  207. Middle East & Africa Methylphenidate Market By Region, From 2019-2024 (USD Billion)
  208. Middle East & Africa Dextroamphetamine Market By Region, From 2019-2024 (USD Billion)
  209. Middle East & Africa Dexmethylphenidate Market By Region, From 2019-2024 (USD Billion)
  210. Middle East Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  211. Africa Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  212. Middle East & Africa Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  213. Middle East & Africa Atomoxetine Market By Region, From 2019-2024 (USD Billion)
  214. Middle East & Africa Bupropion Market By Region, From 2019-2024 (USD Billion)
  215. Middle East & Africa Guanfacine Market By Region, From 2019-2024 (USD Billion)
  216. Middle East Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)
  217. Africa Non-Stimulants ADHD Therapeutics Market By Type, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample